Advocacy & Public Policy
Resources from the American Hospital Association (AHA) on advocacy and public policy health care issues.
On June 28, Rep. Josh Gottheimer, D-N.J., a founding member of the bi-partisan Problem Solvers Caucus, spoke with former AHA Board Chair, Brian Gragnolati, president and chief executive officer at Atlantic Health System in New Jersey, about health care priorities for Congress, including…
AHA urged the Occupational Safety and Health Administration to delay by six months its compliance dates for the recently announced COVID-19 Health Care Emergency Temporary Standard, thus giving hospitals and health systems ample time to implement the policy’s many new requirements.
The AHA and other national hospital organizations today urged Senate leadership and senators supporting a bipartisan $1.2 trillion infrastructure agreement reached with President Biden last week not to extend the 2% mandatory sequestration cut to Medicare or use unspent COVID-19 provider relief…
The AHA joined the Department of Health and Human Services, Centers for Disease Control and Prevention, and other national health care and public health organizations in encouraging COVID-19 vaccination for everyone age 12 and older who is eligible.
The AHA joined the U.S. Chamber of Commerce and other national organizations in urging the 9th Circuit Court of Appeals to affirm a district court decision that found the Public Readiness and Emergency Preparedness Act of 2005 provides broad immunity from tort liability to health care providers and…
The AHA’s opposition to UnitedHealthcare’s now-delayed policy on emergency coverage was picked up by the media and was mentioned in numerous publications, including The New York Times, USA Today, Modern Healthcare, Minneapolis Star Tribune, as well as a local TV interview with AHA President and CEO…
The National Urban League, a strategic partner of AHA, June 15-16 is hosting its annual Legislative Policy Conference as a free virtual event.
The departments of Health and Human Services and Defense will purchase 1.7 million treatment courses of an investigational antiviral drug for $1.2 billion if the Food and Drug Administration approves or authorizes the therapy, the Biden administration announced.
AHA urged UnitedHealthcare to reverse its decision to retroactively deny coverage effective July 1 for emergency department claims the insurer deems non-emergent.
Commenting on the Centers for Medicare…